iSpecimen Inc. (ISPC) stock
ISPCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 17, 2026Score 7/3045% below fair value
$0.53−0.06 (-10.57%)
Close on Nov 18, 2026Market cap $1.34MP/E –Yield –
iSpecimen gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
iSpecimen's gross profit for the twelve months ending Jun 30, 2026 was -$456.94K, down 123.1% year over year. For fiscal 2025 it was $215.67K, down 94.8% from the year before. The highest annual figure on record is $5.89M in fiscal 2021.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $215.67K | -94.8% |
| FY2024 | Dec 31, 2024 | $4.18M | -19.0% |
| FY2023 | Dec 31, 2023 | $5.16M | -8.6% |
| FY2022 | Dec 31, 2022 | $5.65M | -4.1% |
| FY2021 | Dec 31, 2021 | $5.89M | +28.0% |
| FY2020 | Dec 31, 2020 | $4.60M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $68.65K | -74.5% |
| Q1 FY2026 | Mar 31, 2026 | $71.60K | -82.1% |
| Q4 FY2025 | Dec 31, 2025 | -$499.19K | -350.5% |
| Q3 FY2025 | Sep 30, 2025 | -$98.00K | -108.8% |
| Q2 FY2025 | Jun 30, 2025 | $268.96K | -81.3% |
| Q1 FY2025 | Mar 31, 2025 | $400.23K | -70.1% |
| Q4 FY2024 | Dec 31, 2024 | $199.24K | -83.4% |
| Q3 FY2024 | Sep 30, 2024 | $1.11M | -20.0% |
| Q2 FY2024 | Jun 30, 2024 | $1.44M | +86.6% |
| Q1 FY2024 | Mar 31, 2024 | $1.34M | -25.8% |
| Q4 FY2023 | Dec 31, 2023 | $1.20M | -22.8% |
| Q3 FY2023 | Sep 30, 2023 | $1.39M | -1.2% |
| Q2 FY2023 | Jun 30, 2023 | $771.51K | -42.4% |
| Q1 FY2023 | Mar 31, 2023 | $1.80M | +33.3% |
| Q4 FY2022 | Dec 31, 2022 | $1.55M | +17.0% |
| Q3 FY2022 | Sep 30, 2022 | $1.40M | -22.3% |
| Q2 FY2022 | Jun 30, 2022 | $1.34M | -5.4% |
| Q1 FY2022 | Mar 31, 2022 | $1.35M | +0.9% |
| Q4 FY2021 | Dec 31, 2021 | $1.33M | +13.9% |
| Q3 FY2021 | Sep 30, 2021 | $1.80M | +34.1% |
| Q2 FY2021 | Jun 30, 2021 | $1.41M | +37.3% |
| Q1 FY2021 | Mar 31, 2021 | $1.34M | – |
| Q4 FY2020 | Dec 31, 2020 | $1.16M | – |
| Q3 FY2020 | Sep 30, 2020 | $1.35M | – |
| Q2 FY2020 | Jun 30, 2020 | $1.03M | – |
See a number that looks wrong?